| 000 | 00678nam a22002177a 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20180118220836.0 | ||
| 008 | 180118b xxu||||| |||| 00| 0 eng d | ||
| 020 | _a9780309380997 | ||
| 245 | _aGlobal Health Risk Framework: Research and Development of Medical Products: Workshop Summary | ||
| 300 | _a140 p. | ||
| 546 | _aEnglish | ||
| 565 | _aUnedited/Tomas/2018/Jan | ||
| 700 | _aAnne B. Claiborne | ||
| 700 | _aMichelle A. Mancher | ||
| 700 | _aTheresa Wizemann | ||
| 710 |
_4 _aEngineering, and Medicine National Academies of Sciences |
||
| 710 | _aInstitute of Medicine | ||
| 710 | _aBoard on Health Sciences Policy | ||
| 942 |
_2NLM _cMONOGRAPH |
||
| 999 |
_c40838 _d40838 |
||